// App-Quantinova.ai

: Real-World Clinical Outcomes of Multiple Myeloma Patients with High-Risk Cytogenetics Treated with Dararvd, Single Center Experience

Researchers

Presenter

  • Sheeba Ba Aqeel

Principal Investigators

  • Alankrita Taneja

  • Adrienne Groman

  • Sarah Parker

  • Karan Jatwani

  • Arya Mariam Roy

  • Kristopher Attwood

  • Philip L. McCarthy

  • Jens Hillengass

Medical Centers

  • Roswell Park Comprehensive Cancer Center, Buffalo, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

  • carfilzomib Intravenous

  • Lenalidomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved